Arterial CO2 as a potent coronary vasodilator: A preclinical PET/MR validation study with implications for cardiac stress testing
Journal of Nuclear Medicine, ISSN: 2159-662X, Vol: 58, Issue: 6, Page: 953-960
2017
- 15Citations
- 52Captures
- 3Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations15
- Citation Indexes15
- 15
- CrossRef9
- Captures52
- Readers52
- 52
- Mentions3
- News Mentions3
- 3
Most Recent News
Imaging study reveals new ways to widen blood vessels
Pharmacological stress agents given to patients during a cardiac stress test can cause severe side effects, but a new study using PET/MR imaging has revealed
Article Description
Myocardial blood flow (MBF) is the critical determinant of cardiac function. However, its response to increases in partial pressure of arterial CO2 (PaCO2), particularly with respect to adenosine, is not well characterized because of challenges in blood gas control and limited availability of validated approaches to ascertain MBF in vivo. Methods: By prospectively and independently controlling PaCO2 and combining it with 13N-ammonia PET measurements, we investigated whether a physiologically tolerable hypercapnic stimulus (;25 mm Hg increase in PaCO2) can increase MBF to that observed with adenosine in 3 groups of canines: without coronary stenosis, subjected to non-flow-limiting coronary stenosis, and after preadministration of caffeine. The extent of effect on MBF due to hypercapnia was compared with adenosine. Results: In the absence of stenosis, mean MBF under hypercapnia was 2.1 6 0.9 mL/min/g and adenosine was 2.2 6 1.1 mL/min/g; these were significantly higher than at rest (0.9 6 0.5 mL/min/g, P , 0.05) and were not different from each other (P 5 0.30). Under left-anterior descending coronary stenosis, MBF increased in response to hypercapnia and adenosine (P , 0.05, all territories), but the effect was significantly lower than in the left-anterior descending coronary territory (with hypercapnia and adenosine; both P , 0.05). Mean perfusion defect volumes measured with adenosine and hypercapnia were significantly correlated (R 5 0.85) and were not different (P 5 0.12). After preadministration of caffeine, a known inhibitor of adenosine, resting MBF decreased; and hypercapnia increased MBF but not adenosine (P , 0.05). Conclusion: Arterial blood CO2 tension when increased by 25 mm Hg can induce MBF to the same level as a standard dose of adenosine. Prospectively targeted arterial CO2 has the capability to evolve as an alternative to current pharmacologic vasodilators used for cardiac stress testing.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85020194181&origin=inward; http://dx.doi.org/10.2967/jnumed.116.185991; http://www.ncbi.nlm.nih.gov/pubmed/28254864; http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.116.185991; https://dx.doi.org/10.2967/jnumed.116.185991; https://jnm.snmjournals.org/content/58/6/953
Society of Nuclear Medicine
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know